ArticleTargeted oncology2023

Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China.

Minmin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.